| Autor: |
Cornell RF; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Baz R; Moffitt Cancer Center, Tampa, Florida, USA., Richter JR; Hackensack University John Theurer Cancer Center, Hackensack, New Jersey, USA., Rossi A; Weill Cornell Medical College Myeloma Center, New York, New York, USA., Vogl DT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Chen C; UHN Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Shustik C; McGill University Health Centre, Montreal, Quebec, Canada., Alvarez MJ; DarwinHealth Inc., New York, New York, USA., Shen Y; DarwinHealth Inc., New York, New York, USA., Unger TJ; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Ben-Shahar O; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Wang H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Baloglu E; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Senapedis W; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Ma X; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Landesman Y; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Bai X; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Bader J; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Xu H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Marshall T; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Chang H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Walker CJ; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Shah J; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Shacham S; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Kauffman MG; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Hofmeister CC; Ohio State University, Columbus, Ohio, USA. |
Plný text